Is ROP.SW up or down today?
ROP.SW is up 0.13% today, last at 346.54. This stock moved +0.13% versus the prior close.
ROP.SW · ROP.SW
ROP.SW (ROP.SW) is trading at 346.54, up 0.13% on the session. Price action shows weakness or stretched conditions worth watching.
Over the past 7 days, 2 headlines skew mixed. Management stories led the conversation. Recent headlines haven't moved the price much yet (avg impact -0.83%).
Social mentions lean cautious or negative.
Analyst firms are mostly reiterating — no strong directional shift lately.
ROP.SW is up 0.13% today, last at 346.54. This stock moved +0.13% versus the prior close.
Over the past 7 days, 2 headlines skew mixed. Management stories led the conversation. Recent headlines haven't moved the price much yet (avg impact -0.83%). Dominant story: Roche (SWX:ROP) Wins FDA Clearance And EU Backing For Two Key Treatments (1 source, neutral) RSI is 45 — neutral Price below 50-day average — short-term weakness Social (demo): 40% of recent mentions lean bullish — social mood is cautious.
Loaded: Jan 2026 – Jul 2026 (181 days) · Drag or scroll left for earlier dates
Analyst firms are mostly reiterating — no strong directional shift lately.
Query: ROP.SW
0/ 100 index
Based on 11,360 mentions over 30d
Roche (SWX:ROP) Wins FDA Clearance And EU Backing For Two Key Treatments
Roche (SWX:ROP) Appoints Dan Malarek To Lead Its North America Diagnostics Business
Roche showcases intelligent lab solutions and high-precision instruments at ADLM 2026 to help laboratories address workforce and workflow challenges
Roche Holding (SWX:ROP) Could Be 7% Undervalued On Pipeline Momentum - Yahoo Finance
Roche (SWX:ROP) Launches First Fully Automated High Throughput Hepatitis D Test - Yahoo Finance